🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Alexandra S. Zimmer

Oregon Health & Science University

ORCID: 0000-0001-6789-0982
Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 13 papers. Top paper: “Datopotamab–deruxtecan in early-stage breast cancer: the sequential multiple assignment randomized I-SPY2.2 phase 2 trial”.

Datopotamab–deruxtecan in early-stage breast cancer: the sequential multiple assignment randomized I-SPY2.2 phase 2 trial

Nature Medicine(2024)10.1038/s41591-024-03266-2
N/A
0.610DataRank · unranked
13 citations

Jane Meisel, Christina Yau, Hope S. Rugo, Rita Nanda, Marie Davidian +52 more

A Single-Arm, Open-Label Phase II Study of ONC201 in Recurrent/Refractory Metastatic Breast Cancer and Advanced Endometrial Carcinoma

The Oncologist(2023)10.1093/oncolo/oyad164
N/A
0.512DataRank · unranked
12 citations

Yoshimi Endo Greer, Sarah M. Jenkins, Margaret E. Gatti‐Mays, Nicole Houston, Sunmin Lee +11 more

Circulating tumor DNA refines risk stratification of neoadjuvant therapy-resistant breast tumors

Nature Communications(2025)10.1038/s41467-025-65432-5
N/A
0.292DataRank · unranked
6 citations

Nayelis A. Manon, Denise M. Wolf, Samuel Rivero-Hinojosa, Ziad Ahmed, Rosalyn W. Sayaman +20 more

Initial experience in implementing quantitative DCE-MRI to predict breast cancer therapy response in a multi-center and multi-vendor platform setting

Frontiers in Oncology(2024)10.3389/fonc.2024.1395502
N/A
0.241DataRank · unranked
4 citations

Xin Li, Michael Hirano, Assim Saad Eddin, Jeong Youn Lim, Debosmita Biswas +20 more

A Phase II Pilot Study of Anti‐ PD ‐ L1 , Durvalumab, and a PARP Inhibitor, Olaparib in Patients With Metastatic Triple‐Negative Breast Cancer With or Without Germline BRCA Mutation

Cancer Medicine(2025)10.1002/cam4.71220
N/A
0.104DataRank · unranked
1 citations

Ashley Cimino‐Mathews, Stanley Lipkowitz, Min-Jung Lee, Jayakumar R. Nair, B. Brooke Solarz +9 more

A CSF-1R inhibitor both prevents and treats triple-negative breast cancer brain metastases in hematogenous preclinical models

Clinical & Experimental Metastasis(2025)10.1007/s10585-025-10366-x
N/A
0DataRank · unranked
6 citations

Samiur Rahman, Alex Man Lai Wu, Kristine A. Isanogle, Christina M. Robinson, Dinesh Kumar +8 more

Proteogenomic characterization of invasive breast tumors in young women

npj Breast Cancer(2025)10.1038/s41523-025-00793-0
N/A
0DataRank · unranked
3 citations

Jianfang Liu, Anthony R. Soltis, Nicholas W. Bateman, Qingrong Chen, Lori A. Sturtz +70 more

Combination of PARP Inhibitor Olaparib, and PD-L1 Inhibitor Durvalumab, in Recurrent Ovarian Cancer: a Proof-of-Concept Phase II Study

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-0056
N/A
0DataRank · unranked
224 citations

Alexandra S. Zimmer, Michelle R. Padget, Ashley Cimino‐Mathews, Jayakumar R. Nair, Yingmiao Liu +13 more

Consortium for Intracranial Metastasis Academic Research (CIMARa): Global interdisciplinary collaborations to improve outcomes of patients with brain metastases

Neuro-Oncology Advances(2025)10.1093/noajnl/vdaf049
N/A
0DataRank · unranked
2 citations

Amanda E.D. Van Swearingen, Josh Neman, Johanna A. Joyce, Diana M. Cittelly, Manuel Valiente +17 more

HER2 antibody-drug conjugate controls growth of breast cancer brain metastases in hematogenous xenograft models, with heterogeneous blood–tumor barrier penetration unlinked to a passive marker

Neuro-Oncology(2020)10.1093/neuonc/noaa118
N/A
0DataRank · unranked
40 citations

Debbie Wei, Alexandra S. Zimmer, Christina M. Robinson, Imran Khan, Simone Difilippantonio +3 more

“Triple-Negative Breast Cancer Central Nervous System Metastases From the Laboratory to the Clinic”

The Cancer Journal(2021)10.1097/ppo.0000000000000503
N/A
0DataRank · unranked
11 citations

Alexandra S. Zimmer

Intraperitoneal Monocytes plus IFNs as a Novel Cellular Immunotherapy for Ovarian Cancer: Mechanistic Characterization and Results from a Phase I Clinical Trial

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-22-1893
N/A
0DataRank · unranked
21 citations

Franklin Ning, Anna Duemler, Timothy G. Myers, Kathryn Trewhitt, Irene Ekwede +24 more

Phase I Study and Cell-Free DNA Analysis of T-DM1 and Metronomic Temozolomide for Secondary Prevention of HER2-Positive Breast Cancer Brain Metastases

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-22-0855
N/A
0DataRank · unranked
23 citations

Wei Zhang, Seth M. Steinberg, Darryl Nousome, Nicole Houston, Xiaolin Wu +22 more